What Is Autoimmune Encephalitis?
Encephalitis is an infection or an autoimmune response that leads to inflammation of the active tissues in the brain. Swelling is observed in the brain as a result of the inflammation, which can produce headaches, stiff necks, light sensitivity, mental confusion, and seizures. Autoimmune encephalitis is a term that refers to a group of disorders in which the body's immune system attacks and brings about inflammation in healthy brain cells. Antibodies are proteins produced by the body's immune system that mistakenly target brain cells. The disease can be progressive, which means it worsens with time or can be relapsing-remitting with fluctuating flare-up periods and recovery periods very similar to multiple sclerosis. Autoimmune encephalitis is divided into several subgroups based on the antibodies detected. Autoimmune encephalitis can swiftly deteriorate if left untreated. It could result in a coma or severe brain damage. It can be lethal in rare situations.
What Are the Types of Autoimmune Encephalitis?
-
Anti-NMDA Receptor Encephalitis: Antibodies directed against the NMDA receptor in the brain cause anti-NMDA (N-methyl-D-aspartate) receptor encephalitis, which causes neurologic and psychiatric symptoms. NMDA receptors are important for regular brain function. N-methyl-D-aspartate receptors are found all over the brain and play an important role in neuron-to-neuron communication. As a result, when an antibody prevents them from functioning normally, different parts of the brain are affected. A flu-like sickness can precede a kind of autoimmune encephalitis that affects NMDA receptors. It can then result in behavioral abnormalities and atypical movement patterns affecting the mouth and face, as well as cognitive decline and autonomic nervous system dysfunction.
-
LGI1 Antibody Encephalitis: Antibody encephalitis, also known as LGI1 (leucine-rich glioma-inactivated 1) encephalitis, is autoantibody-mediated limbic encephalitis. It is the most frequent antibody-mediated encephalopathy in people above 50 years of age. LGI1 is a released neuronal protein that aids in the regulation of neuronal transmission. LGI1 attaches to receptor proteins on the surface of neurons, which helps LGI1 signal to the neurons. LGI1 is largely present in neurons in the brain, especially the temporal lobe. The temporal lobe of the brain is responsible for memory and emotion, and its disruption can lead to seizures.
-
CASPR2 Antibody Encephalopathy: Anti-contactin-associated protein-like 2 (CASPR2) antibody is a neural-specific antibody linked to autoimmune neurological illnesses such as autoimmune epilepsy and autoimmune encephalitis. Cell adhesion molecule CASPR2 is found in both the central and peripheral nervous systems. Autoantibodies to CASPR2 work by preventing it from interacting with its binding partner, contactin-2. These interactions are crucial for preventing recurrent firing and maintaining nerve resting potential; their disruption can result in hyper-excitability.
-
Anti-GABAA Receptor Encephalitis: Anti-gamma aminobutyric acid-A (GABAA) receptor encephalitis is an autoimmune illness caused by antibodies against GABAA receptors. In the central nervous system (CNS), GABA is the most important inhibitory neurotransmitter. It has a large distribution in the brain and is important for lowering neuronal excitability throughout the central nervous system. Anti-GABAA receptor encephalitis is marked by frequent seizures and unique magnetic resonance imaging (MRI) abnormalities, both of which are useful diagnostic clues.
-
Anti-GABAB Receptor Encephalitis: Anti-gamma aminobutyric acid-B (GABAB) receptor encephalitis is an autoimmune disorder involving the limbic system and mediated by GABAB related antibodies. There is proof that disrupting the structure and function of the GABAB receptor can result in spontaneous seizures. The illness has been linked to lung cancer, necessitating long-term monitoring.
-
GlyR Antibody Encephalitis: Glycine is a significant inhibitory neurotransmitter found in the spinal cord, brain stem, and cerebellum. It is essential for movement regulation and also has sensory functions such as vision and hearing. Glycine's inhibitory actions are mediated by particular glycine receptors. Severe muscular spasms, seizures, stiffness, autonomic instability, agitation, myoclonus, and respiratory failure are all possible symptoms of GlyR dysfunction.
-
Anti-GAD65 Limbic Encephalitis: Antibodies to glutamic-acid-decarboxylase 65 or GAD65 have been linked to a variety of neurological disorders, including limbic encephalitis, stiff person syndrome, and cerebellar ataxia. GAD65 is an important enzyme in the synthesis of GABA or Gamma-Aminobutyric Acid, a neurotransmitter.
-
Anti-DPPX Encephalitis: Autoantibodies targeted against dipeptidyl-peptidase-protein 6 (DPPX) are seen in patients with anti-DPPX encephalitis. DPPX is a voltage-gated potassium channel subunit found in the gut and brain neurons. In the gastrointestinal and neurological systems, these channels are one of the most important components in the creation and propagation of electrical impulses.
-
Anti-IgLON5 Disease: Antibodies to immunoglobulin-like cell adhesion molecule 5 (IgLON5) cause a sleep disorder that is accompanied by a wide range of neurological symptoms such as movement difficulties, gait instability, and brainstem involvement. IgLON5 is an adhesion molecule that is abundantly expressed in the central nervous system, but its function is unknown. The symptoms of the condition are distinct from those of other types of autoimmune encephalitis, and the disease's progression is thought to be slower.
-
Anti-AMPA Receptor Encephalitis: Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors or AMPARs are a type of glutamate receptor that transmits the majority of the brain's rapid, excitatory synaptic signals and are critical for memory and learning. The long-term activation of AMPAR is neurotoxic, and it plays a major role in the onset and development of seizure activity. AMPAR encephalitis is rarer and less prevalent than NMDAR encephalitis, and it is more likely to be connected with an underlying malignancy.
-
Seronegative Autoimmune Encephalitis: Seronegative autoimmune encephalitis refers to autoimmune encephalitis that lacks a pathogenic antibody. When doctors say the patient has seronegative autoimmune encephalitis, it means they have ruled out all other etiologies to the best of their ability. Their reasoning based on the clinical appearance, magnetic resonance imaging, cerebrospinal fluid analysis, and other autoimmune biomarkers has led them to the conclusion that the patient can be diagnosed with autoimmune encephalitis even if a pathogenic antibody has not been detected.
-
Hashimoto Encephalopathy: Hashimoto encephalopathy is an uncommon neurological condition linked to Hashimoto thyroiditis. It is speculated to be an immune-mediated illness in which antibodies that may bind to the thyroid in some people instead bind to the central nervous system, in contrast to the cognitive dysfunction associated with hypothyroidism or hyperthyroidism.
What Are the Symptoms of Autoimmune Encephalitis?
Brain inflammation can result in a number of symptoms involving neurological and psychiatric difficulties. Symptoms can differ greatly from one patient to the next. They can include an abrupt drop in school and work performance, loss of speech, odd movements in the body or seizures, eyesight loss, arm or leg weakness, and sleep issues. Anxiety and mood swings can progress to psychosis, which includes hallucinations, delusions, and catatonia. Symptoms usually appear within a few weeks to a few months. Long-term psychiatric problems which last for months or years are not indicative of autoimmune encephalitis.
How Is Autoimmune Encephalitis Diagnosed?
A multidisciplinary healthcare team composed of a neurologist, rheumatologists, pediatric rheumatologists, psychiatrists, and other experts is ideally suited to make an autoimmune encephalitis diagnosis. A complete medical history, along with a physical examination, as well as blood tests and imaging, are required for diagnosis. If autoimmune encephalitis is suspected, a doctor may recommend a lumbar puncture to check for antibodies, including the N-methyl-D-aspartate (NMDA) antibody, in the cerebral spinal fluid. An abdominal ultrasound may also be conducted to rule out the presence of a tumor. Magnetic resonance imaging of the brain A brain and an electroencephalogram (EEG) test, which analyzes brain waves, are usually included in diagnostic testing. Before a diagnosis of autoimmune encephalitis can be made, other reasons behind brain inflammation, such as infection, must be ruled out.
What Is the Treatment for Autoimmune Encephalitis?
The seriousness of the condition determines the treatment. Early treatment can help to alleviate symptoms and lower the risk of long-term problems. In order to regulate inflammation in the brain, steroids are used along with immunosuppressive medicines. In order to remove dangerous antibodies, plasma exchange is used. Intravenous immunoglobulin (IVIG) is an intravenous drip that is used to inject antibodies from healthy donors' plasma. IVIG lowers inflammation and eliminates dangerous antibodies. Seizures or psychiatric problems may necessitate treatment for some patients. If an ovarian or other tumor is discovered, surgical removal can improve the patient's autoimmune encephalitis substantially. Long-term rehabilitation, such as physical, occupational, and speech therapy, may help patients restore function once the underlying encephalitis is under control.
Conclusion:
An autoimmune encephalitis diagnosis might be life-changing. It might be frightening to go through the process of diagnosis and therapy. The road to recovery can be lengthy and winding. After that, the survivor of autoimmune encephalitis must regain strength, analyze their lifestyle, and develop persistent and supporting behaviors in order to live healthy and productive lives.
